2026-01-08 · Davis Blaine (Chief Financial Officer) · SELL
2026-01-08 · Brunn Carsten (President and CEO) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders102
Shares held9,920,059
Value$106.29M
Percent of shares outstanding32.79%
As of quarter end2026-06-30
RECENT NEWS
RNAC: Cartesian Therapeutics Announces New Employment Inducement Grants
Cartesian Therapeutics Announces Additional Retreatment Data for Descartes-08 Highlighting Deep and Durable Responses in Patients with Myasthenia Gravis